ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer

Zhang, Jian; Liu, Guihong; Dai, Zili; Xie, Fuchuan; Zheng, Ronghui; Yuan, Benchao; Guo, Liyi*广州医学院; 南方医科大学; 6
Gene2023-2-15DOI: 10.1016/j.gene.2022.147095
9閱讀
引用收藏
分享

摘要

Background: Epigenetic mechanisms have been reported to involve in shaping tumor immune microenvironment (TME). However, the role of RNA N6-methyladenosine (m6A) modification in breast cancer has not been fully explored. Methods: Based on m6A modification and TME infiltration characteristics of 2249 breast cancer patients, we comprehensively correlated m6A modification with immune landscape by screening candidate genes, function analysis and constructing m6A signatures. Principal component analysis was used to establish the m6Ascore. Both LASSO and Cox regression analyses were used to evaluate its prognostic value. Functional assays and immunohistochemistry were used to evaluate the expression of m6A regulators and immune cell infiltration. Results: Based on the dysregulated expression of m6A, three distinct clusters were identified that displayed diverse types of tumour-associated TME cell infiltration in breast cancer. Gene signatures, stromal activity, and clinical prognosis were assessed by the m6Ascore. m6Ascore could function as a biomarker for predicting the therapeutic response to targeted therapy and immunotherapy. The dysregulated expression of m6A regulators mediated the immune cell infiltration in the TME. Conclusion: Based on the study, we identified the signature and potential mechanism of m6A modifications that modify TME cell infiltration. Thus, targeting m6A regulators may provide a promising method of treating BRCA.

學科與關鍵詞

關鍵詞
Breast cancerN6-methyladenosineTumor microenvironmentPrognosisBioinformatics
相關
載入中…
  • Classification and immune invasion analysis of breast cancer based on m6A genes
    Qin, Qiang; Fang, Da Lang; Zhou, Weijie; Meng, Yuhua*; Wei, Jie*Annals of Translational Medicine, 2021, 9(18).被引 5
  • The emerging roles and mechanism of m6a in breast cancer progression
    Zhou, Mengying; Dong, Menglu; Yang, Xue; Gong, Jun; Liao, Xinghua*; Zhang, Qi*; Liu, Zeming*Frontiers in Genetics, 2022, 13: 983564.被引 3
  • Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas
    Cai, Zhiqiang; Zhang, Jianbo*; Liu, Ziying; Su, Jiahao; Xu, Jing; Li, Zhenjun; Meng, Hongliang; Zhang, Heng; Huang, Minjie; Zhao, Donghai; Duan, Chuanzhi; He, Xuying*Annals of Translational Medicine, 2021, 9(15): 1241.被引 10
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Gene
發表日期
2023-02-15
卷期
第 853 卷
頁碼
147095
DOI
10.1016/j.gene.2022.147095
語言
ENGLISH
成果收錄
SCIE
資助標註
National Natural Sci-ence Foundation of China; Science and Technology Pro-gram of Guangzhou; Guangzhou Key Medical Discipline Construction Project Fund; [82003212]; [202201010970]; [02-412-B205002-1004042]

作者

  • Z

    Zhang, Jian (第一作者)

    guangzhou med univ

  • L

    Liu, Guihong

查看全部 7 位作者收起作者
  • D

    Dai, Zili

    guangzhou med univ

  • X

    Xie, Fuchuan

    huizhou municipal cent hosp

  • Z

    Zheng, Ronghui

    guangzhou med univ

  • Y

    Yuan, Benchao

    6 · southern med univ

  • G

    Guo, Liyi (通訊)

    6 · southern med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417